Total Payments
$5,189
2024 Payments
$220.40
Companies
22
Transactions
83
Medicare Patients
4,268
Medicare Billing
$336,100
Payment Breakdown by Category
Food & Beverage$3,255 (62.7%)
Travel$1,552 (29.9%)
Education$381.68 (7.4%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,255 | 80 | 62.7% |
| Travel and Lodging | $1,552 | 1 | 29.9% |
| Education | $381.68 | 2 | 7.4% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | $2,678 | 9 | $0 (2021) |
| Abbott Laboratories | $1,229 | 9 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $288.04 | 19 | $0 (2024) |
| Medtronic Vascular, Inc. | $179.58 | 3 | $0 (2018) |
| Amgen Inc. | $92.49 | 5 | $0 (2022) |
| Philips Electronics North America Corporation | $83.93 | 5 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $70.78 | 3 | $0 (2022) |
| Janssen Pharmaceuticals, Inc | $69.42 | 3 | $0 (2022) |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | $64.83 | 4 | $0 (2022) |
| PFIZER INC. | $53.62 | 2 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $220.40 | 14 | Novartis Pharmaceuticals Corporation ($165.29) |
| 2023 | $69.82 | 4 | Novartis Pharmaceuticals Corporation ($43.13) |
| 2022 | $973.79 | 29 | Abbott Laboratories ($480.03) |
| 2021 | $332.49 | 12 | BOSTON SCIENTIFIC CORPORATION ($113.64) |
| 2020 | $422.59 | 8 | Abbott Laboratories ($327.35) |
| 2019 | $2,699 | 11 | Boston Scientific Corporation ($2,483) |
| 2018 | $470.94 | 5 | Abbott Laboratories ($209.91) |
All Payment Transactions
83 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/25/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $9.31 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 10/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/24/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $14.24 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 09/04/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $16.69 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 08/20/2024 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $40.05 | General |
| Category: Vascular | ||||||
| 07/23/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $20.26 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/10/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $8.17 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 07/03/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 06/12/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $13.88 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $19.11 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/01/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $12.12 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 03/06/2024 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $5.80 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 02/29/2024 | Philips North America LLC | (CK4) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $15.06 | General |
| Category: Medical Device | ||||||
| 02/15/2024 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $11.66 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/13/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $18.03 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 11/10/2023 | Novartis Pharmaceuticals Corporation | LEQVIO (Drug), ENTRESTO | Food and Beverage | In-kind items and services | $25.10 | General |
| Category: Cardiology/Vascular Diseases | ||||||
| 05/11/2023 | Lantheus Medical Imaging, Inc. | DEFINITY (Drug) | Food and Beverage | In-kind items and services | $13.14 | General |
| Category: CONTRAST AGENT | ||||||
| 04/13/2023 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $13.55 | General |
| Category: Medical Device | ||||||
| 10/20/2022 | PFIZER INC. | VYNDAQEL (Drug), PAXLOVID | Food and Beverage | In-kind items and services | $28.29 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/23/2022 | Philips Electronics North America Corporation | (5044) MCOT (Device) | Food and Beverage | Cash or cash equivalent | $14.64 | General |
| Category: Medical Device | ||||||
| 09/13/2022 | Merck Sharp & Dohme LLC | VERQUVO (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: CARDIOVASCULAR | ||||||
| 09/08/2022 | SANOFI-AVENTIS U.S. LLC | — | Food and Beverage | In-kind items and services | $29.55 | General |
| 08/09/2022 | Novartis Pharmaceuticals Corporation | ENTRESTO (Drug), LEQVIO | Food and Beverage | In-kind items and services | $18.26 | General |
| Category: CARDIOVASCULAR | ||||||
| 08/05/2022 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: DIABETES | ||||||
| 07/28/2022 | Abbott Laboratories | MITRACLIP (Device) | Food and Beverage | In-kind items and services | $162.23 | General |
| Category: Structural Heart | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 19 | 1,586 | 1,937 | $459,524 | $156,985 |
| 2022 | 14 | 953 | 1,188 | $238,821 | $78,665 |
| 2021 | 19 | 1,244 | 1,520 | $262,671 | $83,498 |
| 2020 | 6 | 485 | 552 | $50,183 | $16,952 |
Total Patients
4,268
Total Services
5,197
Medicare Billing
$336,100
Procedure Codes
63
All Medicare Procedures & Services
63 procedure records from CMS Medicare Utilization — Page 1 of 3
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 262 | 265 | $120,049 | $43,420 | 36.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 235 | 235 | $79,430 | $29,132 | 36.7% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2023 | 59 | 59 | $68,000 | $21,913 | 32.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 122 | 222 | $54,168 | $21,888 | 40.4% |
| J2785 | Injection, regadenoson, 0.1 mg | Office | 2023 | 38 | 146 | $16,924 | $6,503 | 38.4% |
| Q9957 | Injection, perflutren lipid microspheres, per ml | Office | 2023 | 73 | 145 | $14,065 | $5,100 | 36.3% |
| 93351 | Ultrasound of heart with continuous electrocardiogram (ecg) during rest, exercise and/or drug induced stress with review and report | Office | 2023 | 23 | 23 | $12,604 | $4,329 | 34.3% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 55 | 59 | $9,853 | $4,305 | 43.7% |
| 93015 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision and review by physician | Office | 2023 | 63 | 63 | $10,143 | $3,337 | 32.9% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 231 | 258 | $10,062 | $3,051 | 30.3% |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | Office | 2023 | 60 | 60 | $24,398 | $2,776 | 11.4% |
| 93350 | Ultrasound of heart during rest, exercise and/or drug-induced stress with report | Office | 2023 | 18 | 18 | $8,604 | $2,651 | 30.8% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 22 | 22 | $4,884 | $1,946 | 39.8% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Facility | 2023 | 34 | 34 | $9,658 | $1,847 | 19.1% |
| 93308 | Ultrasound of heart, follow-up | Office | 2023 | 14 | 16 | $4,588 | $1,139 | 24.8% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Facility | 2023 | 111 | 138 | $3,612 | $873.81 | 24.2% |
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 11 | 12 | $2,280 | $768.36 | 33.7% |
| 93017 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) | Office | 2023 | 22 | 22 | $2,002 | $638.58 | 31.9% |
| 93010 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report only | Office | 2023 | 66 | 73 | $1,548 | $473.04 | 30.6% |
| 93018 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with review by physician | Office | 2023 | 41 | 41 | $1,352 | $450.80 | 33.3% |
| 93016 | Exercise or drug-induced heart stress test with electrocardiogram (ecg) with supervision by physician | Office | 2023 | 26 | 26 | $1,300 | $444.08 | 34.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 157 | 233 | $66,884 | $22,089 | 33.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 133 | 133 | $47,912 | $16,805 | 35.1% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2022 | 92 | 94 | $43,327 | $14,988 | 34.6% |
| 78452 | Nuclear medicine studies of heart muscle at rest and with stress and spect | Office | 2022 | 27 | 27 | $28,215 | $10,410 | 36.9% |
About Dr. Ryan Cotter, M.D
Dr. Ryan Cotter, M.D is a Nuclear Cardiology healthcare provider based in Denver, Colorado. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/25/2014. The National Provider Identifier (NPI) number assigned to this provider is 1467879726.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Ryan Cotter, M.D has received a total of $5,189 in payments from pharmaceutical and medical device companies, with $220.40 received in 2024. These payments were reported across 83 transactions from 22 companies. The most common payment nature is "Food and Beverage" ($3,255).
As a Medicare-enrolled provider, Cotter has provided services to 4,268 Medicare beneficiaries, totaling 5,197 services with total Medicare billing of $336,100. Data is available for 4 years (2020–2023), covering 63 distinct procedure/service records.
Ad
Practice Information
- Specialty Nuclear Cardiology
- Other Specialties Cardiovascular Disease
- Location Denver, CO
- Active Since 03/25/2014
- Last Updated 10/14/2024
- Taxonomy Code 207UN0901X
- Entity Type Individual
- NPI Number 1467879726
Products in Payments
- GENERAL THERAPIES (Device) $2,428
- MITRACLIP (Device) $520.08
- Ensite Cardiac Mapping System (Device) $209.91
- ENTRESTO (Drug) $187.03
- Supera peripheral stent system (Device) $182.32
- HeartMate 3 Left Ventricular Dev (Device) $171.77
- Advisa (Device) $167.39
- Assurity Pacemaker (Device) $145.03
- WATCHMAN (Device) $113.64
- LEQVIO (Drug) $101.01
- Repatha (Biological) $92.49
- GENERAL THROMBECTOMY (Device) $81.45
- JARDIANCE (Drug) $70.78
- XARELTO (Drug) $69.42
- LifeVest (Device) $64.83
- ELIQUIS (Drug) $60.10
- GENERAL BRADY (Device) $54.49
- NEXLETOL (Drug) $50.37
- Optimizer (Device) $46.69
- Kerendia (Drug) $43.48
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.